C12Y 307/01002
Fumarylacetoacetase
Official title: Fumarylacetoacetase (3.7.1.2)
C12Y307/01002 (Fumarylacetoacetase) appears on 3 US grants and 10 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 10
- Assignees
- 6
- Inventors
- 27
- Latest grant
- 24 Oct 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 1 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 2 |
| 2021 | 0 | 2 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 2 |
By publication year.
Recent patents
- Fumarylacetoacetate hydrolase (FAH)-deficient and immunodeficient rats and uses thereof24 Oct 2023US 11,793,178 B2Yecuris Corporation
- Fumarylacetoacetate hydrolase (Fah)-deficient and immunodeficient rats and uses thereof12 Nov 2019US 10,470,445 B2Yecuris Corporation
- Aromatic amino acid catabolism enzymes17 Apr 2001US 6,218,169 B1E. I. Du Pont de Nemours and Company
- Viral vector compositions and methods of use thereof12 Jun 2025US 2025/0188488 A1LogicBio Therapeutics, Inc.
- Gene therapy for the treatment of ht15 Jun 2025US 2025/0177564 A1LogicBio Therapeutics, Inc.
- Vectors and methods of use12 Aug 2021US 2021/0246433 A1Children's Hospitals and Clinics of Minnesota
- Methods and compositions for producing hepatocytes28 Jan 2021US 2021/0024885 A1
- Vectors and methods of use9 Jul 2020US 2020/0216823 A1Children's Hospitals and Clinics of Minnesota
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.